It further aims to determine the extent to which inflammatory markers—leukocytes, neutrophils, and CRP—correlate with diastolic impairment, and whether this relationship is modulated by the presence of metabolic conditions such as hypertension, type 2 diabetes mellitus, dyslipidemia, or obesity. This evidence concerns the gene CRP and hypertensive disorder.